New Zealand: A Promising Destination For Trials in A Post-Covid-19 World?
Unlike the rest of the world, New Zealand’s speedy and decisive response to Covid-19 has successfully enabled the country’s clinical trials to continue largely unscathed. Allie Nawrat talks to key actors in the New Zealand clinical space about how Covid-1...
Successful Patient Recruitment In a COVID-19 World
Pharmaceutical Solutions (PSL), which is New Zealand and Australia-based, has been geographically fortunate, and our proven strategies have also ensured the continuation and success of our clinical studies. ...
Rapid Study Startup and High Patient Recruitment for US Biotech Clinical Trial
A US-based biotech company was seeking a CRO who could successfully recruit a large number of elderly patients in New Zealand. A challenge squeezed into a three-month recruitment window....
“I wanted to be part of the solution to Covid-19”: Michele Ashby, Executive Director, US
We’re incredibly proud of our Executive Director of Business Development in the United States, Michele Ashby, who is taking part in a US based COVID-19 vaccine trial. Hear from Michele, her insights as a clinical trial participant. ...
COVID-19 and New Zealand’s clinical research sector
In the global race to find a vaccine, we need populations that have had little exposure to Covid-19...
Medicines NZ report estimates clinical trials worth $1.2b over 5 years
Clinical trail prescription medicines have contributed at least $1.2 billion to the New Zealand economy since 2013...
Business Continuity during Covid19
Jacquie Palmer Managing Director details strategic support and focuses for the next 8 weeks....
The Advantages of working with an Independent CRO in Australia and New Zealand.
Tap into 20 years of Clinical Research experience with PSL...
New Zealand Delegation at BIO2019
Pharmaceutical Solutions is attending Bio2019 as part of the NZ delegation. Please come and visit us at the NZ Pavilion - stand 2257...
Pharmaceutical Solutions' Quality Audit
Quality of service and patient safety affirmed....